Please assess the completion status of the following clinical trial:

Trial Title: Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Signed and dated Institutional Review Board (IRB)-approved Informed Consent form for the study~* Received an explanation of the study, including satisfactory answers to all questions related to the proposed research~* Is undergoing physician directed radiation treatment~Exclusion Criteria:~* The potential Subject is unwilling or hesitant to participate for any reason and/or fails to complete the appropriate Informed Consent form

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ancillary-Correlative (blood banking) (Type: None): Samples of blood are collected before, during, and within two weeks after radiation therapy and then stored for analysis of anti-tumor immunity.

Based on this trial design, predict the completion outcome and termination type (if applicable).